港股异动 | 兆科眼科-B(06622)涨超3% 将BRIMOCHOL PF在韩国的独家分销权授予KDP

智通财经01-29

智通财经APP获悉，兆科眼科-B(06622)涨超3%，截至发稿，涨3.61%，报3.16港元，成交额114.09万港元。消息面上，兆科眼科今日公布，兆科(香港)眼科药物有限公司(公司的全资附属公司)与Kwangdong PharmaceuticalCo.,Ltd.(KDP，主要从事药品生产及分销的领先韩国企业)就BRIMOCHOLPF(卡巴可2.75%╱酒石酸溴莫尼丁0.1%固定剂量复方)不含...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2407400447?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-01-29 11:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2407400447","market":"hk","top_or_hot":-1,"title":"港股异动 | 兆科眼科-B(06622)涨超3% 将BRIMOCHOL PF在韩国的独家分销权授予KDP","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，兆科眼科-B(06622)涨超3%，截至发稿，涨3.61%，报3.16港元，成交额114.09万港元。消息面上，兆科眼科今日公布，兆科(香港)眼科药物有限公司(公司的全资附属公司)与Kwangdong PharmaceuticalCo.,Ltd.(KDP，主要从事药品生产及分销的领先韩国企业)就BRIMOCHOLPF(卡巴可2.75%╱酒石酸溴莫尼丁0.1%固定剂量复方)不含...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1063052.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | 兆科眼科-B(06622)涨超3% 将BRIMOCHOL PF在韩国的独家分销权授予KDP</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | 兆科眼科-B(06622)涨超3% 将BRIMOCHOL PF在韩国的独家分销权授予KDP\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-01-29 11:28 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1063052.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，兆科眼科-B(06622)涨超3%，截至发稿，涨3.61%，报3.16港元，成交额114.09万港元。消息面上，兆科眼科今日公布，兆科(香港)眼科药物有限公司(公司的全资附属公司)与Kwangdong PharmaceuticalCo.,Ltd.(KDP，主要从事药品生产及分销的领先韩国企业)就BRIMOCHOLPF(卡巴可2.75%╱酒石酸溴莫尼丁0.1%固定剂量复方)不含...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1063052.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4535","symbol_name":"淡马锡持仓","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1063052.html","article_id":"2407400447","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2407400447","pubTimestamp":1706498913,"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，兆科眼科-B涨超3%，截至发稿，涨3.61%，报3.16港元，成交额114.09万港元。消息面上，兆科眼科今日公布，兆科(香港)眼科药物有限公司与Kwangdong PharmaceuticalCo.,Ltd.就BRIMOCHOLPF不含防腐剂外用滴眼液(该产品)订立分销及供应协议。根据协议条款，公司有权将该产品在韩国的独家分销权授予KDP，以代表公司取得药品注册，并独家进口、推广、分销、营销及销售该产品。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4535":"淡马锡持仓","LU1989763427.SGD":"CPR Invest - Food For Generations A2 Acc SGD-H","BK4177":"软饮料","BK4585":"ETF&股票定投概念","BK1191":"制药","BK4505":"高瓴资本持仓","BK1574":"生物医药B类股","YANG":"三倍做空富时中国ETF-Direxion","06622":"兆科眼科-B","KDP":"Keurig Dr Pepper Inc","BK4588":"碎股","LU1989763690.USD":"东方汇理世代食品基金A2 Acc","BK1583":"高瓴概念","BK1587":"次新股","YINN":"三倍做多富时中国ETF-Direxion","BK4566":"资本集团"},"translate_title":"Hong Kong stock transaction Zhaoke Ophthalmology-B (06622) rose more than 3% and granted the exclusive distribution right of BRIMOCHOL PF in Korea to KDP","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06622":1,"KDP":1,"YANG":1,"YINN":1},"content_text":"智通财经APP获悉，兆科眼科-B(06622)涨超3%，截至发稿，涨3.61%，报3.16港元，成交额114.09万港元。消息面上，兆科眼科今日公布，兆科(香港)眼科药物有限公司(公司的全资附属公司)与Kwangdong PharmaceuticalCo.,Ltd.(KDP，主要从事药品生产及分销的领先韩国企业)就BRIMOCHOLPF(卡巴可2.75%╱酒石酸溴莫尼丁0.1%固定剂量复方)不含防腐剂外用滴眼液(该产品)订立分销及供应协议。根据协议条款，公司有权将该产品在韩国的独家分销权授予KDP，以代表公司取得药品注册，并独家进口、推广、分销、营销及销售该产品。公司将收取一笔不可退还及不可抵扣的预付款，并可按照若干监管成就及商品销售额获得额外的里程碑付款及特许权使用费。","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2407400447"}